Recent advances in oral contraceptive pills: a review of evolving formulations and innovations
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260927Keywords:
Accessibility enhancement, Innovations, OCPs, User-centered designAbstract
Recent innovations in oral contraceptive pills (OCPs) focus on reducing adverse effects and enhancing user control. Key advancements include low-dose/extended-cycle formulations, customization for conditions like polycystic ovary syndrome (PCOS), and improved safety profiles. User-centric features like over-the-counter (OTC) availability (Opill), smart packaging, and digital health integration further improve accessibility and adherence. Since the FDA approved Enovid in 1960, OCP development has continued to evolve. Modifications such as lower doses and extended cycles aim to minimize side effects (e.g., cardiovascular and metabolic) while maintaining efficacy. Customization addresses specific health conditions, improving patient suitability. This review aims to highlight how these developments improve efficacy, reduce side effects, and enhance convenience. This review also outlines key advancements in OCPs, associated explicitly with innovations in formulation, safety, and user-friendliness. For this purpose, this review synthesizes developments in OCP technology and delivery, based on established scientific literature and regulatory milestones. It examines formulation changes, safety enhancements, and user-focused innovations with key examples, including Opill's OTC approval and digital health tools. Thus, this review concludes that innovations in OCPs, spanning formulations, safety, and user experience, offer significant benefits that feature customization, OTC access, and digital integration, empowering women and improving adherence. These advancements also promise a more effective, accessible, and user-controlled contraceptive future.
References
Gandhi AB, Supe PA. Evolution of oral contraceptive pills: historical perspective and modern advances. J Obstet Gynaecol India. 2024;74:109-12. DOI: https://doi.org/10.1007/s13224-024-01988-4
Cameron NA, Blyler CA, Bello NA. Oral Contraceptive Pills and Hypertension: A Review of Current Evidence and Recommendations. Hypertension. 2023;80(5):924-35. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.122.20018
Criss B. New Hormonal Contraceptives and New Roles for Established Hormonal Contraceptives. Current Pediatrics Rep. 2023;11(4):1-62023. DOI: https://doi.org/10.1007/s40124-023-00299-y
Teal S, Edelman A. Contraception selection, effectiveness, and adverse effects: a review. JAMA. 2021;326(24):2507-18. DOI: https://doi.org/10.1001/jama.2021.21392
Basile JN, Bloch MJ. Hormonal contraception in women with hypertension and other cardiovascular risk factors. UpToDate. Waltham, MA. 2025.
Sivasankaran S, Jonnalagadda S. Advances in controlled release hormonal technologies for contraception: a review of existing devices, underlying mechanisms, and future directions. J Control Release. 2020;330:797-811. DOI: https://doi.org/10.1016/j.jconrel.2020.12.044
Gizaw Z, Astale T, Kassie GM. What improves access to primary healthcare services in rural communities? A systematic review. BMC Primary Care. 2022;23(1):313. DOI: https://doi.org/10.1186/s12875-022-01919-0
Katherine K, Alexandra W, Charon A, Maricela C, Alyssa L, Raquel ZR, et al. Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: an online cross-sectional survey. Contraception. 2023;120:109950. DOI: https://doi.org/10.1016/j.contraception.2023.109950
Kiyomi S, Mikio M, Masaho H, Hiroyuki U, Kiyoshi K. Evaluation of newly designed blister packs for easier handling to prevent pill dropping. Patient Prefer Adherence. 2022;16:2543-58. DOI: https://doi.org/10.2147/PPA.S346923
Izzah Z, Zijp TR, Åberg C. Electronic smart blister packages to monitor and support medication adherence: a usability study. Patient Prefer Adherence. 2022;16:2543-58. DOI: https://doi.org/10.2147/PPA.S374685
Lina El T, Dalia K, Antoine AAM, Ali K, Sehrish A, Joseph N. Efficacy of dienogest vs combined oral contraceptive for pain associated with endometriosis: a randomized study. Europ J Obstet Gynecol Reproduct Biol. 2021;267:205-12. DOI: https://doi.org/10.1016/j.ejogrb.2021.10.029
Howard SA, Benhabbour SR. Non-Hormonal Contraception. J Clin Med. 2023;12(14):4791. DOI: https://doi.org/10.3390/jcm12144791
Summer M, Matthew E, Stephen AB, Laura JP, Emma R, Chris R, et al Tuuned in: use of an online contraceptive decision aid for women increases reproductive self-efficacy and knowledge; results of an experimental clinical trial. BMC Digital Health. 2023;1(1):1-11. DOI: https://doi.org/10.1186/s44247-023-00034-z
Daniels K, Abma JC. Current contraceptive status among women aged 15-49: United States, 2017-2019. NCHS Data Brief, no 388. Hyattsville, MD: National Center for Health Statistics. 2020.
ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI; Panay N, Anderson RA, Bennie A, Cedars M, Davies M, Ee C, et al. Evidence-based guideline: premature ovarian insufficiency. Climacteric. 2024;27(6):510-20. DOI: https://doi.org/10.1080/13697137.2024.2423213
Bhatt A. Applied intelligence in clinical drug development: Potential benefits and emerging concerns. Perspect Clin Res. 2025;16(3):127-31. DOI: https://doi.org/10.4103/picr.picr_37_25
Kimberly D, Joyce CA. Current Contraceptive Status Among Women Aged 15-49: United States, 2017-2019. NCHS Data Brief No. 388, 2020. Available at: https://www.cdc.gov/nchs/products/databriefs/db388.htm. Accessed on 02 February 2026.
Gilbert AL, Hoffman BL. Contraceptive Technology: Present and Future. Obstet Gynecol Clin N Am. 2021;48(4):723-35. DOI: https://doi.org/10.1016/j.ogc.2021.07.001
Douxfils J, Klipping C, Duijkers I, Virginie K, Marie M, Catherine M, et al. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception. 2020;102(6):396-402. DOI: https://doi.org/10.1016/j.contraception.2020.08.015
Gemzell-Danielsson K, Cagnacci A, Chabbert-Buffet N, Jonathan D, Jean-Michel F, Ali K, et al. A novel estetrol-containing combined oral contraceptive: European expert panel review. Europ J Contracept Reproduct Health Care. 2022;27(5):373-83. DOI: https://doi.org/10.1080/13625187.2022.2093850
Emerson C. Habiller des statues. Studia Bruxellae. 2024;15(1):102-9. DOI: https://doi.org/10.3917/stud.015.0102
Datta ST, Kumar U. Mind the Gaps: Cases in Gynaecology, Sexual and Reproductive Health E-Book. Elsevier Health Sciences. 2021.
Cohen M, Posner S, Kent C, Antoinette T. Nguyen; Kathryn M. Curtis; Naomi K. Tepper. Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention MMWR Editorial and Production Staff (Serials) MMWR Editorial Board CONTENTS. 2024. Available at: https://www.cdc.gov/mmwr/volumes/73/rr/pdfs/rr7304a1-H.pdf. Accessed on 02 February 2026.
Zheng A, Nelson HN, McCall-Hosenfeld JS, Erik B, Lehman MS, Cynthia H. Chuang: Recent Intimate Partner Violence and Oral Contraceptive Pill Adherence in a Cohort of Reproductive-Aged Women. J Women’s Health. 2022;31(12):1703-9. DOI: https://doi.org/10.1089/jwh.2021.0622
Hillen C, Sachs C, Buhling KJ, Monserat E, Sebastian G, Juliana V, et al. Evaluating Patient-Reported Adherence And Safety for Oral Contraception Treatment in Women via a Direct-To-Consumer Prescription Platform: A Cross-Sectional Study. Telemed J e-Health. 2024;30(12):2876-82. DOI: https://doi.org/10.1089/tmj.2024.0168
Bennink C, Gennip M, Gerrits MGF, Egberts JFM, Gemzell-D. Health benefits of combined oral contraceptives-a narrative review. Europ J Contracept Reproduct Health Care. 2024;29(2):40-52. DOI: https://doi.org/10.1080/13625187.2024.2317295
Harris ML, Egan N, Forder PM, Deborah B, Aaron LS, Vanessa EM, et al. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reproductive Health. 2022;19(1):111. DOI: https://doi.org/10.1186/s12978-022-01413-x
Bearak J, Maddow-Zimet I, Leong E, Kost K. O16Contraceptive failure rates: New estimates for individual methods and method combinations. Contraception. 2022;116:73. DOI: https://doi.org/10.1016/j.contraception.2022.09.021
Seidu AA, Ameyaw EK, Ahinkorah BO, Leonard B, Samuel D, Augustine A, et al. Sexual and reproductive health education and its association with ever use of contraception: a cross-sectional study among women in urban slums, Accra. Reproductive Health. 2022;19(1):7. DOI: https://doi.org/10.1186/s12978-021-01322-5
Dehlendorf C, Fox E, Silverstein IA, Alexis H, Reiley R, Kelsey H, et al. Development of the Patient-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning Care scale. Contraception. 2021;103(5):310-5. DOI: https://doi.org/10.1016/j.contraception.2021.01.008
Xie H, Li Y, Wen C, Wang Q. Contraceptive Use Disparities in Asian American Women in 2015-2016: California Health and Interview Survey. Sexes. 2024;5(3):386-97. DOI: https://doi.org/10.3390/sexes5030028
Otte R, Thissen VTM, Mulder BC. (Dis)continuation of the oral contraceptive pill: A focus group approach in the Netherlands. Heliyon. 2023:e19405. DOI: https://doi.org/10.1016/j.heliyon.2023.e19405
Rothschild CW, Richardson BA, Guthrie BL, P Kithao, T Omurwa,J Mukabi, et al. Contributions of side effects to contraceptive discontinuation and method switch among Kenyan women: a prospective cohort study. 2022;129(6):926-37. DOI: https://doi.org/10.1111/1471-0528.17032
Fuentes L, Douglas-Hall A, Geddes CE, Megan L. Kavanaugh: Primary and reproductive healthcare access and use among reproductive aged women and female family planning patients in 3 states. ProQuest. 2023:e0285825. DOI: https://doi.org/10.1371/journal.pone.0285825
Gozzi P, Persson M, Nielsen A, Kilander H, Kågesten AE, Iwarsson KE, et al. Contraceptive access and use among women with migratory experience living in high-income countries: a scoping review. BMC Public Health. 2024;24(1):2569. DOI: https://doi.org/10.1186/s12889-024-19778-y
Shumet T, Geda NR, Hassan JA. Barriers to modern contraceptive utilization in Ethiopia. Contracept Reproduct Med. 2024;9(1):47. DOI: https://doi.org/10.1186/s40834-024-00311-w
Congy J, Bouyer JE. Low-income women and use of prescribed contraceptives in the context of full health insurance coverage in France, 2019. Contraception. 2023;121:109976. DOI: https://doi.org/10.1016/j.contraception.2023.109976
Liddelow C, Mullan B, Boyes M. Adherence to the oral contraceptive pill: the roles of health literacy and knowledge. Health Psychol Behavioral Med. 2020;8(1):587-600. DOI: https://doi.org/10.1080/21642850.2020.1850288
Wondimagegene YA, Debelew GT, Koricha ZB. Effectiveness of peer-led education interventions on contraceptive use, unmet need, and demand among adolescent girls in Gedeo Zone, South Ethiopia. A cluster randomized controlled trial. Global Health Action. 2023;16(1):2160543. DOI: https://doi.org/10.1080/16549716.2022.2160543
Downloads
Published
How to Cite
Issue
Section
